Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications
H Zhang, K Yang, F Chen, Q Liu, J Ni, W Cao… - Frontiers in …, 2022 - frontiersin.org
The CCL2-CCR2 axis is one of the major chemokine signaling pathways that has received
special attention because of its function in the development and progression of …
special attention because of its function in the development and progression of …
Targeting galectin-3 in inflammatory and fibrotic diseases
S Bouffette, I Botez, F De Ceuninck - Trends in Pharmacological Sciences, 2023 - cell.com
Abstract Galectin (Gal)-3 is a β-galactoside-binding lectin emerging as a key player in
cardiac, hepatic, renal, and pulmonary fibrosis and inflammation, respiratory infections …
cardiac, hepatic, renal, and pulmonary fibrosis and inflammation, respiratory infections …
Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling
L Bai, W Lu, S Tang, H Tang, M Xu, C Liang… - Cell Death & …, 2022 - nature.com
We previously documented that M2-like macrophages exert a hepatoprotective effect in
acute-on-chronic liver failure (ACLF) by inhibiting necroptosis signalling. Nevertheless, the …
acute-on-chronic liver failure (ACLF) by inhibiting necroptosis signalling. Nevertheless, the …
The emerging role of leptin in obesity-associated cardiac fibrosis: Evidence and mechanism
Y Mao, K Zhao, P Li, Y Sheng - Molecular and Cellular Biochemistry, 2023 - Springer
Cardiac fibrosis is a hallmark of various cardiovascular diseases, which is quite commonly
found in obesity, and may contribute to the increased incidence of heart failure arrhythmias …
found in obesity, and may contribute to the increased incidence of heart failure arrhythmias …
Ultrasonic microbubble cavitation deliver gal-3 shRNA to inhibit myocardial fibrosis after myocardial infarction
W Li, Q Jin, L Zhang, S He, Y Song, L Xu, C Deng… - Pharmaceutics, 2023 - mdpi.com
Galectin-3 (Gal-3) participates in myocardial fibrosis (MF) in a variety of ways. Inhibiting the
expression of Gal-3 can effectively interfere with MF. This study aimed to explore the value of …
expression of Gal-3 can effectively interfere with MF. This study aimed to explore the value of …
Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy
H Liu, SY Hwang, SS Lee - Pharmaceuticals, 2023 - mdpi.com
Abnormal cardiac function in the setting of cirrhosis and in the absence of a primary cardiac
disease is known as cirrhotic cardiomyopathy. The pathogenesis of cirrhotic cardiomyopathy …
disease is known as cirrhotic cardiomyopathy. The pathogenesis of cirrhotic cardiomyopathy …
Understanding aconite's anti-fibrotic effects in cardiac fibrosis
Z Xing, C Yang, Y Feng, J He, C Peng, D Li - Phytomedicine, 2024 - Elsevier
Background The prevalence of cardiac fibrosis, intricately linked to various cardiovascular
diseases, continues to rise. Aconite, a traditional Chinese herb renowned for its …
diseases, continues to rise. Aconite, a traditional Chinese herb renowned for its …
PPARδ activation improves cardiac mitochondrial homeostasis in desmin deficient mice but does not alleviate systolic dysfunction
D Palioura, K Mellidis, K Ioannidou-Kabouri… - Journal of Molecular and …, 2023 - Elsevier
Peroxisome proliferator-activated receptor (PPAR) δ is a major transcriptional regulator of
cardiac energy metabolism with pleiotropic properties, including anti-inflammatory, anti …
cardiac energy metabolism with pleiotropic properties, including anti-inflammatory, anti …
High blood galectin-3 level associated with risk of frailty in aging
X Ji, Z Jiang, Y Qiu, J Yu, Y Zhang, J Wang… - Frontiers in …, 2023 - frontiersin.org
Background Frailty is one of the most problematic expressions of population aging, but its
underlying mechanism has not been fully elucidated. Circulating galectin-3 (Gal-3) is …
underlying mechanism has not been fully elucidated. Circulating galectin-3 (Gal-3) is …
Involvement of Matricellular Proteins in Cellular Senescence: Potential Therapeutic Targets for Age-Related Diseases
M Fujita, M Sasada, T Iyoda, F Fukai - International Journal of Molecular …, 2024 - mdpi.com
Senescence is a physiological and pathological cellular program triggered by various types
of cellular stress. Senescent cells exhibit multiple characteristic changes. Among them, the …
of cellular stress. Senescent cells exhibit multiple characteristic changes. Among them, the …